世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Arginase Deficiency Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3850
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、89ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アルギナーゼ欠損症治療薬の市場動向
・企業の競争状況、市場シェア
・アルギナーゼ欠損症治療薬の種類別市場規模と予測2016-2027（経口、注射）
・アルギナーゼ欠損症治療薬の用途別市場規模と予測2016-2027（病院、ドラッグストア、その他）
・アルギナーゼ欠損症治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・アルギナーゼ欠損症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アルギナーゼ欠損症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アルギナーゼ欠損症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・アルギナーゼ欠損症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Helsinn Healthcare、Novartis Pharmaceuticals、Horizon Pharma、Medicis Pharmaceutical）
・結論

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.

Market Analysis and Insights: Global Arginase Deficiency Therapeutics Market
The global Arginase Deficiency Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Arginase Deficiency Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Arginase Deficiency Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Arginase Deficiency Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Arginase Deficiency Therapeutics market.

Global Arginase Deficiency Therapeutics Scope and Market Size
Arginase Deficiency Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Arginase Deficiency Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospital
Drugs Stores
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Helsinn Healthcare
Novartis Pharmaceuticals
Horizon Pharma
Medicis Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arginase Deficiency Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Arginase Deficiency Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Arginase Deficiency Therapeutics Market Perspective (2016-2027)
2.2 Arginase Deficiency Therapeutics Growth Trends by Regions
2.2.1 Arginase Deficiency Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Arginase Deficiency Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Arginase Deficiency Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Arginase Deficiency Therapeutics Industry Dynamic
2.3.1 Arginase Deficiency Therapeutics Market Trends
2.3.2 Arginase Deficiency Therapeutics Market Drivers
2.3.3 Arginase Deficiency Therapeutics Market Challenges
2.3.4 Arginase Deficiency Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Arginase Deficiency Therapeutics Players by Revenue
3.1.1 Global Top Arginase Deficiency Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Arginase Deficiency Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Arginase Deficiency Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Arginase Deficiency Therapeutics Revenue
3.4 Global Arginase Deficiency Therapeutics Market Concentration Ratio
3.4.1 Global Arginase Deficiency Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arginase Deficiency Therapeutics Revenue in 2020
3.5 Arginase Deficiency Therapeutics Key Players Head office and Area Served
3.6 Key Players Arginase Deficiency Therapeutics Product Solution and Service
3.7 Date of Enter into Arginase Deficiency Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Arginase Deficiency Therapeutics Breakdown Data by Type
4.1 Global Arginase Deficiency Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Arginase Deficiency Therapeutics Forecasted Market Size by Type (2022-2027)

5 Arginase Deficiency Therapeutics Breakdown Data by Application
5.1 Global Arginase Deficiency Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Arginase Deficiency Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Arginase Deficiency Therapeutics Market Size (2016-2027)
6.2 North America Arginase Deficiency Therapeutics Market Size by Type
6.2.1 North America Arginase Deficiency Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Arginase Deficiency Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Arginase Deficiency Therapeutics Market Size by Type (2016-2027)
6.3 North America Arginase Deficiency Therapeutics Market Size by Application
6.3.1 North America Arginase Deficiency Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Arginase Deficiency Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Arginase Deficiency Therapeutics Market Size by Application (2016-2027)
6.4 North America Arginase Deficiency Therapeutics Market Size by Country
6.4.1 North America Arginase Deficiency Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Arginase Deficiency Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Arginase Deficiency Therapeutics Market Size (2016-2027)
7.2 Europe Arginase Deficiency Therapeutics Market Size by Type
7.2.1 Europe Arginase Deficiency Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Arginase Deficiency Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Arginase Deficiency Therapeutics Market Size by Type (2016-2027)
7.3 Europe Arginase Deficiency Therapeutics Market Size by Application
7.3.1 Europe Arginase Deficiency Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Arginase Deficiency Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Arginase Deficiency Therapeutics Market Size by Application (2016-2027)
7.4 Europe Arginase Deficiency Therapeutics Market Size by Country
7.4.1 Europe Arginase Deficiency Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Arginase Deficiency Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Arginase Deficiency Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type
8.2.1 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application
8.3.1 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region
8.4.1 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Arginase Deficiency Therapeutics Market Size (2016-2027)
9.2 Latin America Arginase Deficiency Therapeutics Market Size by Type
9.2.1 Latin America Arginase Deficiency Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Arginase Deficiency Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Arginase Deficiency Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Arginase Deficiency Therapeutics Market Size by Application
9.3.1 Latin America Arginase Deficiency Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Arginase Deficiency Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Arginase Deficiency Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Arginase Deficiency Therapeutics Market Size by Country
9.4.1 Latin America Arginase Deficiency Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Arginase Deficiency Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Arginase Deficiency Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type
10.2.1 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application
10.3.1 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country
10.4.1 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Helsinn Healthcare
11.1.1 Helsinn Healthcare Company Details
11.1.2 Helsinn Healthcare Business Overview
11.1.3 Helsinn Healthcare Arginase Deficiency Therapeutics Introduction
11.1.4 Helsinn Healthcare Revenue in Arginase Deficiency Therapeutics Business (2016-2021)
11.1.5 Helsinn Healthcare Recent Development
11.2 Novartis Pharmaceuticals
11.2.1 Novartis Pharmaceuticals Company Details
11.2.2 Novartis Pharmaceuticals Business Overview
11.2.3 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Introduction
11.2.4 Novartis Pharmaceuticals Revenue in Arginase Deficiency Therapeutics Business (2016-2021)
11.2.5 Novartis Pharmaceuticals Recent Development
11.3 Horizon Pharma
11.3.1 Horizon Pharma Company Details
11.3.2 Horizon Pharma Business Overview
11.3.3 Horizon Pharma Arginase Deficiency Therapeutics Introduction
11.3.4 Horizon Pharma Revenue in Arginase Deficiency Therapeutics Business (2016-2021)
11.3.5 Horizon Pharma Recent Development
11.4 Medicis Pharmaceutical
11.4.1 Medicis Pharmaceutical Company Details
11.4.2 Medicis Pharmaceutical Business Overview
11.4.3 Medicis Pharmaceutical Arginase Deficiency Therapeutics Introduction
11.4.4 Medicis Pharmaceutical Revenue in Arginase Deficiency Therapeutics Business (2016-2021)
11.4.5 Medicis Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Arginase Deficiency Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Arginase Deficiency Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Arginase Deficiency Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Arginase Deficiency Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Arginase Deficiency Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Arginase Deficiency Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Arginase Deficiency Therapeutics Market Share by Regions (2022-2027)
Table 10. Arginase Deficiency Therapeutics Market Trends
Table 11. Arginase Deficiency Therapeutics Market Drivers
Table 12. Arginase Deficiency Therapeutics Market Challenges
Table 13. Arginase Deficiency Therapeutics Market Restraints
Table 14. Global Arginase Deficiency Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Arginase Deficiency Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Arginase Deficiency Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arginase Deficiency Therapeutics as of 2020)
Table 17. Ranking of Global Top Arginase Deficiency Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Arginase Deficiency Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Arginase Deficiency Therapeutics Product Solution and Service
Table 21. Date of Enter into Arginase Deficiency Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Arginase Deficiency Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Arginase Deficiency Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Arginase Deficiency Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Arginase Deficiency Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Arginase Deficiency Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Arginase Deficiency Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Arginase Deficiency Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Arginase Deficiency Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Arginase Deficiency Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Arginase Deficiency Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Arginase Deficiency Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Arginase Deficiency Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Arginase Deficiency Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Arginase Deficiency Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Arginase Deficiency Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Arginase Deficiency Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Arginase Deficiency Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Arginase Deficiency Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Arginase Deficiency Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Arginase Deficiency Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Helsinn Healthcare Company Details
Table 62. Helsinn Healthcare Business Overview
Table 63. Helsinn Healthcare Arginase Deficiency Therapeutics Product
Table 64. Helsinn Healthcare Revenue in Arginase Deficiency Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Helsinn Healthcare Recent Development
Table 66. Novartis Pharmaceuticals Company Details
Table 67. Novartis Pharmaceuticals Business Overview
Table 68. Novartis Pharmaceuticals Arginase Deficiency Therapeutics Product
Table 69. Novartis Pharmaceuticals Revenue in Arginase Deficiency Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Novartis Pharmaceuticals Recent Development
Table 71. Horizon Pharma Company Details
Table 72. Horizon Pharma Business Overview
Table 73. Horizon Pharma Arginase Deficiency Therapeutics Product
Table 74. Horizon Pharma Revenue in Arginase Deficiency Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Horizon Pharma Recent Development
Table 76. Medicis Pharmaceutical Company Details
Table 77. Medicis Pharmaceutical Business Overview
Table 78. Medicis Pharmaceutical Arginase Deficiency Therapeutics Product
Table 79. Medicis Pharmaceutical Revenue in Arginase Deficiency Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Medicis Pharmaceutical Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arginase Deficiency Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Arginase Deficiency Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Other Case Studies
Figure 8. Arginase Deficiency Therapeutics Report Years Considered
Figure 9. Global Arginase Deficiency Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Arginase Deficiency Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Arginase Deficiency Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Arginase Deficiency Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Arginase Deficiency Therapeutics Market Share by Players in 2020
Figure 14. Global Top Arginase Deficiency Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arginase Deficiency Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Arginase Deficiency Therapeutics Revenue in 2020
Figure 16. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Arginase Deficiency Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Arginase Deficiency Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Arginase Deficiency Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Arginase Deficiency Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Arginase Deficiency Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Arginase Deficiency Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Arginase Deficiency Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Arginase Deficiency Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Arginase Deficiency Therapeutics Market Share by Region (2016-2027)
Figure 38. China Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Arginase Deficiency Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Arginase Deficiency Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Arginase Deficiency Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Arginase Deficiency Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Arginase Deficiency Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Arginase Deficiency Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Arginase Deficiency Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Helsinn Healthcare Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2016-2021)
Figure 58. Novartis Pharmaceuticals Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2016-2021)
Figure 59. Horizon Pharma Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2016-2021)
Figure 60. Medicis Pharmaceutical Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

以下、関連資料のご紹介

世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3851 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のオルニチントランスカルバミラーゼ（OTC）欠損症治療市場規模・現状・予測（2021年-2027年）

Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4628 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、オルニチントランスカルバミラーゼ（OTC）欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、...

世界のオルニチントランスカルバミラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Ornithine Transcarbamylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5918 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、オルニチントランスカルバミラーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のオルニチン-トランスカルバミラーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Ornithine-Transcarbamylase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-4629 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オルニチン-トランスカルバミラーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DTX-301、SEL-313、SHP-641、PRX-OTC、その他）、用途別市場規模（病院、クリニック、その...

世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年）

Global ACTH Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3753 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ACTH欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（先天性、後天性）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のビオチニダーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Biotinidase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-5622 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ビオチニダーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症）、用途別市場規模（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬...

世界の亜鉛欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Zinc Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5049 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、亜鉛欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の成長ホルモン欠乏療法市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5761 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、成長ホルモン欠乏療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非経口、経皮、経口、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Treatment Market The global Arginase Deficiency Treatme…
世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年） CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were fi…
世界のオルニチントランスカルバミラーゼ（OTC）欠損症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market The global Ornithine Transcarbamylase (OTC) Deficiency Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-s…
世界のオルニチントランスカルバミラーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Ornithine transcarbamylase (OTC) deficiency is a genetic disorder arising due to inadequate levels of OTC, an enzyme that helps decompose and eliminate unwanted nitrogen from the human body. This process is also known as the urea cycle. Deficiency of this enzyme causes excessive nitrogen accumulatio…
世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年） ACTH is an adrenocorticotropic hormone, which is a hormone secreted by the anterior pituitary gland, which can maintain the normal form and function of the adrenal glands. The main role of ACTH is to promote the secretion of glucocorticoids by the adrenal cortex, maintaining the normal physiological…